Experience

Cysbio

• Denmark
• Biotechnology Research
• 1 - 100 Employee

• Co-founder and Director, Amino acid Technologies

  • Mar 2019 - Present



DTU - Technical University of Denmark

• Denmark
• Research Services
• 700 & Above Employee

• Research Scientist

  • Mar 2012 - Dec 2018

  * Metabolic engineering of E. coli for production of amino acid * Enzyme engineering of pathways to boost the production of amino acids * Adaptive evolution to overcome chemical toxicity and enhance uptake of cheap carbon sources * Fed batch fermentation to boost serine production * Synthetic tools for construction of cheap inducibale system Output so far: 2 publications and 2 patents * Metabolic engineering of E. coli for production of amino acid * Enzyme engineering of pathways to boost the production of amino acids * Adaptive evolution to overcome chemical toxicity and enhance uptake of cheap carbon sources * Fed batch fermentation to boost serine production * Synthetic tools for construction of cheap inducibale system Output so far: 2 publications and 2 patents



RWTH Aachen University

• Germany
• Research Services
• 700 & Above Employee

• Post-doctoral Fellow

  • Jan 2011 - Dec 2011

  * Optimized random mutagenesis method SeSaM which offers library enriched with consecutive mutations and transversions. * Worked part time for spin off SeSAM gmbH * Successfully accomplished two enzyme engineering campaigns which were in collaboration with Roche and Evonik. Results: 3 publications and 2 patents * Optimized random mutagenesis method SeSaM which offers library enriched with consecutive mutations and transversions. * Worked part time for spin off SeSAM gmbH * Successfully accomplished two enzyme engineering campaigns which were in collaboration with Roche and Evonik. Results: 3 publications and 2 patents



Jacobs University Bremen

• Germany
• Research Services
• 200 - 300 Employee

• PhD in Biochemical Engineering

  • Jul 2007 - Jan 2011

  Advanced Sequence Saturation Mutagenesis method for random incorporation of consecutive mutations and transversions which are unfeasible by epPCR. The new protocol is being used in spin off company SeSaM-Biotech GmbH Mutant libraries and has been shown useful in protein evolution campaigns for non-natural properties. Advanced Sequence Saturation Mutagenesis method for random incorporation of consecutive mutations and transversions which are unfeasible by epPCR. The new protocol is being used in spin off company SeSaM-Biotech GmbH Mutant libraries and has been shown useful in protein evolution campaigns for non-natural properties.